As the Covid-19 pandemic continues to spread, over 2.7 million cases have been confirmed, as well as 193,000 deaths. Pharmaceutical companies are continuing to explore treatments to alleviate the symptoms of the disease and improve the chances of survival on severely affected patients.

A number of drugs are currently being investigated for their ability to reduce one of the primary causes of death in patients, acute respiratory distress syndrome. Click here to read more.